We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
Published Online:https://doi.org/10.2217/fvl-2016-0036

Aim: A prospective study was undertaken to establish the prevalence of enterovirus D68 (EV-D68) in the northwest of England. Patients & samples: In the period 24 October through 31 December 2014, respiratory samples were screened by a specific real-time PCR and EV-D68 was identified by nucleotide sequence-based typing. Results: Enterovirus was detected in 7.4% of samples and EV-D68 was confirmed in 32 cases. Phylogenetic analysis showed that EV-D68 strains corresponded to clades A and B. Clinical presentation of cases ranged from mild to severe respiratory infection. The majority of cases had comorbidities that might predispose to severe infection. Conclusion: EV-D68 was circulating in our region during late 2014 and has the potential to cause severe disease.

References

  • 1 Romero J, Modlin J. Introduction to the human enteroviruses and parechoviruses. In: Principles and Practice of Infectious Diseases. Mandell GL, Bennett JE, Dolin R (Eds). Elsevier, Amsterdam, The Netherlands, 2066 (2015).
  • 2 Schieble JH, Fox VL, Lennette EH. A probable new human picornavirus associated with respiratory diseases. Am. J. Epidemiol. 85(2), 297–310 (1967).
  • 3 Holm-Hansen CC, Midgley SE, Fischer TK. Global emergence of enterovirus D68: a systematic review. Lancet Infect. Dis. 16(5), e64–e75 (2016).
  • 4 CDC. Severe respiratory illness associated with enterovirus D68. MMWR Morb. Mortal. Wkly Rep. 63(36), 798–799 (2014).
  • 5 Poelman R, Schuffenecker I, Van Leer-Buter C, Josset L, Niesters HGM, Lina B. European surveillance for enterovirus D68 during the emerging North-American outbreak in 2014. J. Clin. Virol. 71, 1–9 (2015).
  • 6 Poelman R, Schölvinck EH, Borger R, Niesters HGM, van Leer-Buter C. The emergence of enterovirus D68 in a Dutch university medical center and the necessity for routinely screening for respiratory viruses. J. Clin. Virol. 62, 1–5 (2015).
  • 7 Tokarz R, Firth C, Madhi SA et al. Worldwide emergence of multiple clades of enterovirus 68. J. Gen. Virol. 93(Pt 9), 1952–1958 (2012).
  • 8 Bragstad K, Jakobsen K, Rojahn AE et al. High frequency of enterovirus D68 in children hospitalised with respiratory illness in Norway, autumn 2014. Influenza Other Respir. Viruses 9(2), 59–63 (2015).
  • 9 Imamura T, Fuji N, Suzuki A et al. Enterovirus 68 among children with severe acute respiratory infection, The Philippines. Emerg. Infect. Dis. 17(8), 1430–1435 (2011).
  • 10 Linsuwanon P, Puenpa J, Suwannakarn K et al. Molecular epidemiology and evolution of human enterovirus serotype 68 in Thailand, 2006–2011. PLoS ONE 7(5), e35190 (2012).
  • 11 Liu Y, Sheng J, Fokine A et al. Virus structure. Structure and inhibition of EV-D68, a virus that causes respiratory illness in children. Science 347(6217), 71–74 (2015).
  • 12 Sun L, Meijer A, Froeyen M et al. Antiviral activity of broad-spectrum and enterovirus-specific inhibitors against clinical isolates of enterovirus D68. Antimicrob. Agents Chemother. 59(12), 7782–7785 (2015).
  • 13 Davison KL. The epidemiology of acute meningitis in children in England and Wales. Arch. Dis. Child. 88(8), 662–664 (2003).
  • 14 Lauinger IL, Bible JM, Halligan EP, Aarons EJ, MacMahon E, Tong CYW. Lineages sub-lineages and variants of enterovirus 68 in recent outbreaks. PLoS ONE 7(4), e36005 (2012).
  • 15 CDC. Clusters of acute respiratory illness associated with human enterovirus 68 – Asia, Europe, and United States. MMWR Morb. Mortal. Wkly Rep. 60(38), 1301–1304 (2011).
  • 16 Meijer A, van der Sanden S, Snijders BEP et al. Emergence and epidemic occurrence of enterovirus 68 respiratory infections in The Netherlands in 2010. Virology 423(1), 49–57 (2012).
  • 17 Leshem E. Notes from the field: acute flaccid myelitis among persons aged ≤21 years – United States, August 1–November 13, 2014. MMWR Morb. Mortal. Wkly Rep. 63(53), 1243–1244 (2015).
  • 18 Kreuter JD, Barnes A, McCarthy JE et al. A fatal central nervous system enterovirus 68 infection. Arch. Pathol. Lab. Med. 135(6), 793–796 (2011).
  • 19 Oberste MS, Maher K, Schnurr D et al. Enterovirus 68 is associated with respiratory illness and shares biological features with both the enteroviruses and the rhinoviruses. J. Gen. Virol. 85(Pt 9), 2577–2584 (2004).
  • 20 Baggen J, Thibaut HJ, Staring J et al. Enterovirus D68 receptor requirements unveiled by haploid genetics. Proc. Natl Acad. Sci. USA 113(5), 1399–1404 (2016).